1-3 of 3
Suzanne Borgel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Joel Morris, Donn G. Wishka, Omar D. Lopez, Vladimir Rudchenko, Guangfei Huang, Sierra N. Hoffman, Suzanne Borgel, Kyle Georgius, John Carter, Howard Stotler, Mark W. Kunkel, Jerry M. Collins, Melinda G. Hollingshead, Beverly A. Teicher
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (4): 625–631.
https://doi.org/10.1158/1535-7163.MCT-20-0738
Published: 01 April 2021
View article titled, F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd
Open the PDF for F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd in another window
Includes: Supplementary data
Journal Articles

Synergistic antitumor activity of Bevacizumab in combination with HIF-1 inhibition.

Annamaria Rapisarda, Melinda Hollingshead, Mark Raffeld, Bradley Gehrs, Suzanne Borgel, John Carter, Carrie Bonomi, Robert Shoemaker, Giovanni Melillo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B17.
Published: 01 November 2007
View article titled, Synergistic antitumor activity of Bevacizumab in combination with HIF-1 inhibition.
Journal Articles

Evidence of in vivo efficacy for the indenoisoquinolines linked with pharmacodynamic markers for γH2AX

Melinda Hollingshead, Suzanne Borgel, John Carter, Carrie Bonomi, Raymond Divelbiss, Howard Stotler, Kelly Dougherty, Nathaniel Greenberg, Gurmeet Kaur, Yves Pommier, P Monks, Ralph Parchment, Robert Kinders, Joseph Tomaszewski, James Doroshow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C18.
Published: 01 November 2007
View article titled, Evidence of in vivo efficacy for the indenoisoquinolines linked with pharmacodynamic markers for γH2AX